Scotts Miracle-Gro price target raised to $105 from $90 at Barclays

Barclays analyst Gaurav Jain raised the firm’s price target on Scotts Miracle-Gro to $105 from $90 and keeps an Overweight rating on the shares. The company reported better than expected pricing and margin for the U.S. Consumer division in Q1. This reaffirms the bullish case on Scotts and the company is well on track to achieve its $6-8 free cash flow per share goal, the analyst tells investors in a research note.